Scrip's Complete Guide to Cancer Therapies: A biotech revolution?

Scrip's Complete Guide to Cancer Therapies: A biotech revolution?

Therapeutic

This new study provides an overview of current cancer therapies, with particular focus on lung and gastrointestinal cancer, and provides essential information on the new cancer treatments and their impact on the current market.

Scrip's Complete Guide to Cancer Therapies covers all major topics, including:

The current understanding of cancer, and the resulting therapeutic research focus
The latest innovations in cancer therapies
Key market drivers
The cancer indications with the highest number of unmet needs

The information in this report will provide a thorough basis for readers to get ahead in the challenging cancer treatment market.

Published: February 2001
Ref: BS1087E
Pages: 243
Price: £795/$1,670/¥191,000

For further information about this report, please contact our Customer Helpdesk on:
Tel: +44 (0)20 8332 8965 / 66
Fax: +44 (0)20 8332 8992
E-mail: [email protected]

Contents

Introduction to cancer
Background
Staging of cancers
Treatment options
Types of cancer

Established therapeutic products
Established anticancer drug classes
Cytotoxic drugs
Types of cytotoxic drugs
Hormonal agents
Hormones and cancer
Types of hormonal therapies
Marketed drugs
Hormonal anticancer therapies in clinical development
Chemosensitisers and radiosensitisers
Radioprotective and chemoprotective agents

Immunotherapies marketed and in development
Introduction
Cancer immunotherapy
Cancer vaccines
Monoclonal antibodies
Cytokines

Angiogenesis and matrix metalloproteinases inhibitors in development
Introduction
Angiogenesis inhibitors
The process of angiogenesis
Endogenous angiogenic factors and inhibitors
Angiogenesis as a therapeutic target
Angiogenesis drugs in development
Further considerations
Matrix metalloproteinases
MMPIs in clinical development
Further considerations

Other biotherapies in development
Introduction
Apoptosis
Apoptosis drugs in development
Telomerase and telomerase inhibitors
Telomerase inhibitors in development
Gene therapy
Gene therapy strategies
Gene therapy vectors
Gene therapy products in development
Antisense therapy
Drugs in development
Anti-adhesion therapies
Integrin linked kinase and protein kinase B inhibitors
Single transduction inhibitors

The cancer market
Cancer statistics worldwide
Cancer in the US
Cancer in the European Union
Cancer in the UK
Cancer in Japan
Specific cancers
The anticancer drug market
Market drivers
Market values
Leading companies
Leading cancer drugs

Company profiles
Aeterna Laboratories
AltaRex Corporation
Astra Zeneca
Aventis Pharma
Biomira
Bristol-Myers Squibb
Cell Genesys
Corixa Corporation
EntreMed
Genentech
Genta
Geron Corporation
ILEX Oncology
Immunex Corporation
Intracel Corp
Lorus Therapeutics
Novartis Pharma
Pharmacia Corp